Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
MicroVision Inc

Start price
Target price
Perf. (%)
€2.36
29.11.23
€2.00
29.11.24
3.49%
02.12.23

Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
MicroVision Inc

Start price
Target price
Perf. (%)
€2.23
23.11.23
€2.00
23.11.24
5.92%
29.11.23

Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€60.00
08.09.22
€80.00
31.12.24
35.00%
24.06.23

Could be very worthwhile Investment >20% year
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€16.10
07.05.22
€20.00
07.05.23
222.26%
08.05.23

Could be very worthwhile Investment >20% year
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.50
03.01.23
€30.00
31.12.25
76.00%
05.05.23

Could be very worthwhile Investment >20% year
buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€16.97
06.02.23
€27.00
31.12.25
87.64%
05.05.23

Could be very worthwhile Investment >20% year
buy
Immunogen Inc.

Start price
Target price
Perf. (%)
€3.98
09.01.23
€8.00
31.12.25
178.89%
05.05.23

Could be very worthwhile Investment >20% year
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€6.10
19.12.22
€18.00
31.12.24
226.15%
05.05.23

Could be very worthwhile Investment >20% year
buy
Madrigal Pharmaceuticals inc.

Start price
Target price
Perf. (%)
€66.50
30.09.22
€120.00
31.12.24
324.36%
05.05.23

Could be very worthwhile Investment >20% year
buy
Meridian Bioscience Inc.

Start price
Target price
Perf. (%)
€19.00
28.01.22
€20.00
28.01.23
62.63%
29.01.23

Could be worthwhile Investment >10% per year
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€32.60
28.12.22
€40.00
28.12.23
50.15%
02.01.23

buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.40
01.11.21
€15.00
01.11.22
79.03%
02.11.22

Could be worthwhile Investment >10% per year
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€29.94
20.10.21
€35.00
31.12.23
65.15%
05.08.22

Could be very worthwhile Investment >20% year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.19
27.06.22
€1.00
27.06.23
26.17%
09.07.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
buy
Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€79.50
27.06.22
€100.00
27.06.23
40.88%
28.06.22

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Little innovation
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€10.20
16.11.21
€11.00
31.12.24
0.98%
28.06.22

Could be very worthwhile Investment >20% year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.10
13.06.22
€1.00
13.06.23
7.81%
25.06.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
buy
Zosano Pharma Corp.

Start price
Target price
Perf. (%)
€1.43
02.05.22
€1.00
02.05.23
18.02%
05.05.22

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Growths slower than the competition
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.015
20.02.22
€7.50
20.03.22
61900.00%
21.03.22

Could be worthwhile Investment >10% per year
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€11.37
17.06.21
€18.00
09.03.22
95.60%
10.03.22

Could be very worthwhile Investment >20% year
buy
Epizyme Inc.

Start price
Target price
Perf. (%)
€1.10
27.01.22
€1.00
27.01.23
41.00%
05.02.22

Could be worthwhile Investment >10% per year
Capable Management
Bad culture
buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€0.99
30.11.21
€1.00
30.11.22
36.36%
11.12.21

Could be very worthwhile Investment >20% year
Good culture
Innovative
Few uniques
buy
Anavex Life Sciences Corp

Start price
Target price
Perf. (%)
€4.28
21.10.20
€6.00
04.11.21
348.60%
05.11.21

Could be worthwhile Investment >10% per year
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€13.13
25.08.20
€25.20
04.11.21
120.37%
05.11.21

Could be worthwhile Investment >10% per year
buy
Veracyte Inc.

Start price
Target price
Perf. (%)
€30.20
23.08.20
€45.00
04.11.21
49.01%
05.11.21

Could be worthwhile Investment >10% per year